Advanced Search

 

Study ID Status Title Patient Level Data
112914 Completed The Sumatriptan and Naratriptan Pregnancy Registry
112917 Completed GlaxoSmithKline International Bupropion Pregnancy Registry
112921 Completed Impact of immediate or delayed prophylactic antipyretic treatment on the immunogenicity, reactogenicity and safety of GlaxoSmithKline Biologicals’ pneumococcal vaccine 1024850A and the co-administered DTPa-combined vaccines Study Listed on ClinicalStudyDataRequest.com
112924 Completed Drug Use Investigation for AMERGE (naratriptan hydrochloride) Tablet
112925 Completed Special Drug Use Investigation for AMERGE Tablet (Long-term)
112929 Completed A Phase 2a Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1265744 Monotherapy Versus Placebo in HIV-1 Infected Adults (ITZ112929)
112930 Completed An open-label, randomized, adaptive design, two-period crossover study in cancer patients to evaluate the bioequivalence of alternative formulations of lapatinib compared to the commercial tablet
112931 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ Hib-MenCY-TT (MenHibrix®) vaccine 792014 compared to Merck & Co, Inc. Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) vaccine in healthy infants and toddlers
112933 Completed Booster vaccination with pneumococcal vaccine GSK1024850A or Prevenar™ co-administered with Hiberix™ in children primed with the same vaccines Study Listed on ClinicalStudyDataRequest.com
112934 Completed A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING112934)
112937 Completed Retrospektive Studie zu Patientinnen, die pränatal, perinatal oder postnatal prophylaktisch oder therapeutisch mit Fondaparinux behandelt wurden
112940 Completed A longitudinal 2-year bone marrow study of eltrombopag olamine (SB-497115-GR) in previously treated adults, with chronic immune (idiopathic) thrombocytopenic purpura (ITP)
112941 Completed A randomized, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of a supratherapeutic dose of GSK1349572 250 mg and a randomized, open-label study to evaluate the effects of omeprazole 40 mg daily and a high fat meal on the pharmacokinetics of GSK1349572 50 mg in healthy adult subjects (ING112941)
112949 Completed Long-term extension study of the efficacy of the 580299 vaccine in the prevention of HPV-16 and/or HPV-18 associated cervical intraepithelial neoplasia (CIN) in Japanese women vaccinated in the primary vaccination study NCT00316693 Study Listed on ClinicalStudyDataRequest.com
112950_1 Completed Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
112952_1 Completed Demographic and clinical differences in patients receiving PI and NNRTI regimens, & Factors associated with hepatic outcomes
112956 Terminated Identification and characterisation of bacteria causing chronic cough among children in the United Kingdom
112957 Completed Phase III, partially double-blind study to evaluate consistency and immunogenicity of 3 lots of GSK Biologicals' Hib conjugate vaccine 208108 versus ActHIB and Pentacel at 2, 4, 6 and 15-18 months of age in healthy infants
112958 Completed A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects with post-stroke upper limb spasticity
112961 Completed A pilot study to assess the antiviral activity of GSK1349572 containing regimen in antiretroviral therapy (ART)-experienced, HIV-1-infected adult subjects with raltegravir resistance
112963 Completed Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Quadrivalent Influenza Vaccine FLU Q-QIV (GSK2282512A) When Administered Intramuscularly to Adults 18 Years of Age and Older Study Listed on ClinicalStudyDataRequest.com
112967 Completed A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury Study Listed on ClinicalStudyDataRequest.com
112988 Terminated A randomized, single-blind (Investigator and Subject), placebo-controlled, single ascending dose study exploring the preliminary safety, tolerability, and pharmacokinetics of GSK1223249 administered by intravenous (IV) infusion to subjects with relapsing forms of multiple sclerosis, not on disease modifying therapy
112989 Completed Validation of a New Shortness of Breath with Daily Activities Questionnaire in patients with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
112993 Completed A study to evaluate safety and immunogenicity of a booster dose of two formulations of GSK Biologicals’ pneumococcal candidate vaccine in healthy young adults Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.